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The ribosome plays a universally conserved role in catalyzing protein synthesis. Kondrashov et al.
(2011) now provide evidence that the loss of function of ribosomal protein L38 in mice leads to
a selective reduction in the translation of Hox mRNAs, thus suggesting that ribosomal proteins
play a critical role during embryonic development.In eukaryotes, during the initiation step of
translation, 40S ribosomal subunits are
recruited to the mRNA by proteins known
as translation initiation factors (Sonen-
berg and Hinnebusch, 2009). The 40S
ribosome complex with associated
factors navigates the mRNA 50 untrans-
lated region (UTR) in search of the initia-
tion codon. When the initiation codon is
encountered, translation initiation factors
are released and the 60S ribosomal
subunit joins to form a translationally
competent 80S ribosome. Translational
control of gene expression is largely
achieved via modulation of the activity of
translation initiation factors, such as
eukaryotic translation initiation factors
4E (eIF4E) and eIF2 (Sonenberg and Hin-
nebusch, 2009). These factors affect the
translation of a subset of mRNAs, which
harbor specific features in their 50 UTRs.
In contrast to eIFs, it is generally thought
that ribosomes have a constitutive rather
than regulatory role in mRNA translation
(Stillman, 2001). However, in this issue,
Kondrashov et al. (2011) provide evidence
suggesting that the ribosome regulates
gene expression during embryonic devel-
opment by promoting the translation of
a subset of mRNAs.
Ribosomal RNA (rRNA) serves as the
catalytic core of the ribosome, whereas
ribosomal proteins (RPs) are thought to
facilitate optimal rRNA processing and
folding (Stillman, 2001). Notwithstanding
the differences in their composition andsize, the constitutive role of the ribosome
in catalyzing protein synthesis is con-
served across all kingdoms of life
(Stillman, 2001). Unexpected observa-
tions have emerged when studying
human disorders collectively referred to
as ‘‘ribosomopathies,’’ in which genetic
alterations occur in components of the
ribosome machinery, including RPs. For
instance, in Diamond-Blackfan anemia,
mutations in several different RPs are
associated with bone marrow failure and
congenital birth defects leading to malfor-
mations in limb, face, heart, and kidney
development (Ganapathi and Shimamura,
2008), thus suggesting that RPs play
an important role during embryonic
development.
Kondrashov et al. (2011) now show that
mutations in RPL38 are responsible for
developmental abnormalities displayed
by the tail-short (Ts/+) mice, which exhibit
skeletal patterning defects, including
homeotic transformations, and compro-
mised neural tube patterning. Surpris-
ingly, Ts/+ embryos do not exhibit
alterations in global translation as com-
pared to wild-type littermates. However,
the translation of a subset of mRNAs en-
coding Hox homeoproteins in embryonic
tissues, including the neural tube and
somites, is strongly reduced in Ts/+
embryos (Figure 1). Homeoproteins play
an evolutionarily conserved role in
controlling cell positioning and tissue
patterning, which are the processesCellduring which cells attain appropriate
developmental fates (Gehring, 1987).
Thus, these findings suggest that the
ribosome plays a regulatory, rather
than a constitutive role in modulation of
gene expression during embryonic
development.
Important issues concerning the mech-
anism by which RPL38 controls transla-
tion must now be addressed. A critical
issue is whether RPL38 controls transla-
tion initiation of HoxmRNAs as an integral
part of the ribosome or as an extrariboso-
mal entity. The authors addressed this
question by showing that in cytoplasmic
extracts RPL38 is predominately found
associated with ribosomes. In contrast,
another ribosomal protein, RPL26, which
binds to the 50 UTR of p53 mRNA and
increases its translation in response to
DNA damage, appears to function in
an extraribosomal manner (Chen and
Kastan, 2010). Thus, it is evident that
future experiments will be required to
address the question of ribosomal versus
extraribosomal mechanisms of actions of
ribosomal proteins in translational control.
Several other outstanding questions
remain to be answered: Does RPL38
directly bind cis-regulatory elements in
Hox mRNAs to control their translation?
Do trans-acting factors (such as RNA-
binding proteins or microRNAs) play
a role in this process? And what can we
expect in adult tissues? Significantly, indi-
viduals suffering from ribosomopathies145, April 29, 2011 ª2011 Elsevier Inc. 333
Figure 1. The Interface between Development and Translational Control
The loss of function of ribosomal protein RPL38 (L38) leads to a selective reduction in Hox mRNA
translation. Reduced Hox proteins in the somites (red), which are precursors of vertebrae, leads to skeletal
malformations characteristic of the Ts/+ phenotype. Tissue heterogeneity in the expression of ribosomal
proteins (depicted in yellow, blue, and green) suggests that the changes in ribosome composition play an
important role in the regulation of translation during embryonic development.(such as Diamond-Blackfan anemia and
X-linked dyskeratosis congenita) have
increased predisposition to cancer
(Ganapathi and Shimamura, 2008). The
mechanisms underlying ribosomal
dysfunction in cancer are still largely
unknown, but the study of Kondrashov
et al. raises the possibility that dysregula-
tion of ribosomal function may lead to
selective changes in translation that
promote malignant transformation.
RPs are ubiquitously expressed and
highly abundant (Stillman, 2001). None-
theless, the authors report that RPL38 is
enriched in developing tissues including
eye, somites, and neural tubewhere aber-
rant tissue patterning is observed in Ts/+
mice (Kondrashov et al., 2011). This
heterogeneity in the expression of RPs
appears to be a general phenomenon
during embryonic development, inas-
much as 72 RPs show inter-tissue varia-
tion in their expression levels. Previous
findings in yeast by Komili et al. (2007)
showing that RP paralogs appear to be334 Cell 145, April 29, 2011 ª2011 Elsevier Infunctionally distinct gave rise to a provoc-
ative model of translational regulation
wherein alterations in the composition of
ribosomes lead to their ‘‘specialization’’
toward specific subsets of mRNAs
(that is, a ‘‘ribosome code’’). However,
mammalian genomes, with a few excep-
tions, do not contain RP paralogs (Uechi
et al., 2001). Although it is plausible that
the differences in RP levels between
tissues reflect their extraribosomal func-
tions, tissue heterogeneity in the expres-
sion of individual RPs in the developing
mouse embryo suggests that if a ‘‘ribo-
some code’’ exists in mammals, it may
be established via modulation of RP
expression.
Several key questions need to be
answered to establish the existence of
a ‘‘ribosome code.’’ Molecular mecha-
nisms that explain how the changes in
the ribosomal composition and/or struc-
ture selectively affect translation of
specific subsets of mRNAs are still
elusive, and mRNA elements that corre-c.spond to ‘‘ribosome codes’’ are yet to
be discovered. Given that both RPs and
rRNA are extensively modified (Stillman,
2001), it is plausible that these modifica-
tions contribute to the ‘‘specialization’’ of
the ribosome. Consistent with this notion,
a key enzyme responsible for rRNA modi-
fications is mutated in the X-linked dys-
keratosis congenita syndrome resulting
in selective impairment of translation
(Yoon et al., 2006).
It is thought that the appearance of RPs
in the ribosome predecessors of the RNA
world accommodated the synthesis of
longer polypeptide chains via stimulation
of rRNA folding and improved efficacy
and accuracy of mRNA translation (Fox,
2010). The findings of Kondrashov et al.
(2011) raise the interesting possibility
that some ribosomal proteins may have
evolved to endow ribosomes with the
capacity to modulate translation of
specific mRNAs. The challenge posed
by this intriguing study is to understand
the mechanisms by which the ribosome
controls translation in eukaryotes.REFERENCES
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